Irbesartan chemical structure
Find information on thousands of medical conditions and prescription drugs.

Irbesartan

Irbesartan is an angiotensin II receptor antagonist used mainly for the treatment of hypertension. Irbesartan was discovered by Sanofi Research (now part of Sanofi-Aventis). It is jointly marketed by Sanofi-Aventis and Bristol-Myers Squibb under the trade names Aprovel®, Karvea®, and Avapro®. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
Ibuprofen
Idarubicin
Idebenone
IFEX
Iloprost
Imatinib mesylate
Imdur
Imipenem
Imipramine
Imiquimod
Imitrex
Imodium
Indahexal
Indapamide
Inderal
Indocin
Indometacin
Infliximab
INH
Inosine
Intal
Interferon gamma
Intralipid
Invanz
Invirase
Iontocaine
Iotrolan
Ipratropium bromide
Iproniazid
Irbesartan
Iressa
Irinotecan
Isocarboxazid
Isoflurane
Isohexal
Isoleucine
Isomonit
Isoniazid
Isoprenaline
Isordil
Isosorbide
Isosorbide dinitrate
Isosorbide mononitrate
Isotretinoin
Itraconazole
Ivermectin
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Irbesartan is one of the class that patients may be prescribed if they cannot tolerate the ACE-inhibitor drugs, such as perindopril. The usual reason is because of dry cough, attributed to delayed breakdown of bradykinin by ACE. Irbesartan may help to delay the progression of diabetic nephropathy, a form of chronic renal failure due to diabetes.

Irbesartan is also available in a combination formulation with hydrochlorothiazide, marketed as CoAprovel®.

Read more at Wikipedia.org


[List your site here Free!]


Application for diabetic nephropathy withdrawn. (Rx: Panel divided on irbesartan).(Brief Article) : An article from: Internal Medicine News $5.95 Irbesartan: A Medical Dictionary, Bibliography, And Annotated Research Guide To Internet References $32.66
Angiotensin II Inhibitors Offer Renal Protection.(for people with type 2 diabetes) : An article from: Internal Medicine News $5.95

Do irbesartan and amlodipine reduce cardiovascular events in diabetic patients? - Patient Oriented Evidence That Matters: practice recommendations from
Berl T, Hunsicker LG, Lewis JB, et al. Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt ...
Irbesartan-associated persistent edema of the eyelids, face, and neck - Case Reports
Abstract Irbesartan, an angiotensin II receptor antagonist (AIIRA), is an antihypertensive agent that inhibits the activity of angiotensin II by selectively ...
Effect of long-term irbesartan treatment on endothelium-dependent vasodilation in essential hypertensive patients
ABSTRACT Endothelial dysfunction plays a pivotal role in the development of essential hypertension and its complications. The purpose of this study is ...
Prolonged cholestasis associated with irbesartan - Drug Points
A 62 year old woman was admitted with a week's history of jaundice. Examination showed deep icterus and hepatomegaly. She had no history of liver disease, ...
Cyclosporine After Punctal Plugs
A postmenopausal woman with a 5-year history of dry, scratchy burning eyes reported experiencing constant discomfort, despite hourly application of artificial ...
Olmesartan for hypertension
Synopsis Olmesartan (Benicar) is an angiotensin-II receptor blocker (ARB) labeled for the treatment of hypertension as monotherapy or in combination ...
For those intolerant to ACE inhibitors and ARBs, what is the best therapy for reducing the risk of diabetic nephropathy?
EVIDENCE-BASED ANSWER Angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) are the first-line agents for reducing ...
Diabetic nephropathy: common questions
Diabetic nephropathy, or diabetic kidney disease, affects 20 to 30 percent of patients with diabetes. It is a common cause of kidney failure. Diabetic ...

Home Contact Resources Exchange Links ebay